SPIRONOLACTONE and CARDIAC FAILURE

4,483 reports of this reaction

1.6% of all SPIRONOLACTONE reports

#16 most reported adverse reaction

Overview

CARDIAC FAILURE is the #16 most commonly reported adverse reaction for SPIRONOLACTONE, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 4,483 FDA adverse event reports linking SPIRONOLACTONE to CARDIAC FAILURE. This represents approximately 1.6% of all 279,694 adverse event reports for this drug.

SPIRONOLACTONE has an overall safety score of 85 out of 100. Patients taking SPIRONOLACTONE who experience cardiac failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CARDIAC FAILURE4,483 of 279,694 reports

CARDIAC FAILURE is a less commonly reported adverse event for SPIRONOLACTONE, but still significant enough to appear in the safety profile.

Other Side Effects of SPIRONOLACTONE

In addition to cardiac failure, the following adverse reactions have been reported for SPIRONOLACTONE:

DYSPNOEA — 10,389 reports
FATIGUE — 8,181 reports
NAUSEA — 7,817 reports
DIARRHOEA — 7,419 reports
ACUTE KIDNEY INJURY — 6,785 reports
DIZZINESS — 6,239 reports
HEADACHE — 5,859 reports
HYPOTENSION — 5,819 reports
OFF LABEL USE — 5,556 reports
DRUG INEFFECTIVE — 5,207 reports

Other Drugs Associated with CARDIAC FAILURE

The following drugs have also been linked to cardiac failure in FDA adverse event reports:

BISOPROLOL FUMARATE DOPAMINE HYDROCHLORIDE DRONEDARONE EDOXABAN TOSYLATE EPLERENONE FEBUXOSTAT TABLETS 40 MG FEBUXOSTAT TABLETS 80 MG ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE IVABRADINE MEXILETINE HYDROCHLORIDE MILRINONE LACTATE PARICALCITOL SACUBITRIL AND VALSARTAN TAFAMIDIS TETRAHYDROZOLINE HCL TOLVAPTAN TORSEMIDE VONOPRAZAN FUMARATE WHITE PETROLEUM

Frequently Asked Questions

Does SPIRONOLACTONE cause CARDIAC FAILURE?

CARDIAC FAILURE has been reported as an adverse event in 4,483 FDA reports for SPIRONOLACTONE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CARDIAC FAILURE with SPIRONOLACTONE?

CARDIAC FAILURE accounts for approximately 1.6% of all adverse event reports for SPIRONOLACTONE, making it a notable side effect.

What should I do if I experience CARDIAC FAILURE while taking SPIRONOLACTONE?

If you experience cardiac failure while taking SPIRONOLACTONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

SPIRONOLACTONE Full Profile All Drugs Causing CARDIAC FAILURE Pfizer Laboratories Div Pfizer Inc Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.